Masimo blinked. Today, the medical device maker dropped the controversial corporate bylaws it had adopted to thwart new director nominations — a corporate defense tactic that caused much consternation in the governance world. The company’s move, which comes in the middle of a high-profile court case filed by Politan Capital Management, is a big victory …
Substack is the home for great culture
